BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuo PT, Zeng Z, Salim N, Mattarollo S, Wells JW, Leggatt GR. The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer. Front Med (Lausanne) 2018;5:271. [PMID: 30320116 DOI: 10.3389/fmed.2018.00271] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 18.0] [Reference Citation Analysis]
Number Citing Articles
1 Guerrero D, Vo HTM, Lon C, Bohl JA, Nhik S, Chea S, Man S, Sreng S, Pacheco AR, Ly S, Sath R, Lay S, Missé D, Huy R, Leang R, Kry H, Valenzuela JG, Oliveira F, Cantaert T, Manning JE. Evaluation of cutaneous immune response in a controlled human in vivo model of mosquito bites. Nat Commun 2022;13:7036. [DOI: 10.1038/s41467-022-34534-9] [Reference Citation Analysis]
2 Roewe J, Walachowski S, Sharma A, Berthiaume KA, Reinhardt C, Bosmann M. Bacterial polyphosphates induce CXCL4 and synergize with complement anaphylatoxin C5a in lung injury. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.980733] [Reference Citation Analysis]
3 Gurrea-Rubio M, Fox DA. The dual role of CD6 as a therapeutic target in cancer and autoimmune disease. Front Med (Lausanne) 2022;9:1026521. [PMID: 36275816 DOI: 10.3389/fmed.2022.1026521] [Reference Citation Analysis]
4 Kragstrup TW, Sørensen AS, Brüner M, Lomholt S, Nielsen MA, Schafer P, Deleuran B. MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2. Int Immunopharmacol 2022;112:109267. [PMID: 36179420 DOI: 10.1016/j.intimp.2022.109267] [Reference Citation Analysis]
5 DiNatale A, Castelli MS, Nash B, Meucci O, Fatatis A. Regulation of Tumor and Metastasis Initiation by Chemokine Receptors. J Cancer 2022;13:3160-76. [PMID: 36118530 DOI: 10.7150/jca.72331] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zúñiga LA, Leßmann T, Uppal K, Bisek N, Hong E, Rasmussen CE, Karlsson JJ, Zettler J, Holten-Andersen L, Bang K, Thakar D, Lee YC, Martinez S, Sabharwal SS, Stark S, Faltinger F, Kracker O, Weisbrod S, Müller R, Voigt T, Bigott K, Tabrizifard M, Breinholt VM, Mirza AM, Rosen DB, Sprogøe K, Punnonen J. Intratumoral delivery of TransCon TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction. Cancer Cell Int 2022;22:286. [PMID: 36123697 DOI: 10.1186/s12935-022-02708-6] [Reference Citation Analysis]
7 Subedi S, Park YP. SPRUCE: Single-cell Pairwise Relationships Untangled by Composite Embedding model.. [DOI: 10.1101/2022.09.16.508327] [Reference Citation Analysis]
8 Caroff E, Meyer EA, Äänismaa P, Froidevaux S, Keller M, Piali L. Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles as Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125. J Med Chem 2022. [PMID: 35969159 DOI: 10.1021/acs.jmedchem.2c00676] [Reference Citation Analysis]
9 Yero A, Shi T, Routy J, Tremblay C, Durand M, Costiniuk CT, Jenabian M. FoxP3+ CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation. Front Immunol 2022;13:962912. [DOI: 10.3389/fimmu.2022.962912] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Peckham H, Webb K, Rosser EC, Butler G, Ciurtin C. Gender-Diverse Inclusion in Immunological Research: Benefits to Science and Health. Front Med 2022;9. [DOI: 10.3389/fmed.2022.909789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Roewe J, Walachowski S, Sharma A, Berthiaume KA, Reinhardt C, Bosmann M. Bacterial Polyphosphates Induce CXCL4 and Synergize with Complement Anaphylatoxin C5a in Lung Injury.. [DOI: 10.1101/2022.07.05.498838] [Reference Citation Analysis]
12 Bottomley MJ, Harden PN, Wood KJ, Hester J, Issa F. Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients. Front Immunol 2022;13:901273. [DOI: 10.3389/fimmu.2022.901273] [Reference Citation Analysis]
13 Satarkar D, Patra C. Evolution, Expression and Functional Analysis of CXCR3 in Neuronal and Cardiovascular Diseases: A Narrative Review. Front Cell Dev Biol 2022;10:882017. [DOI: 10.3389/fcell.2022.882017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lee JY, Nguyen B, Mukhopadhyay A, Han M, Zhang J, Gujar R, Salazar J, Hermiz R, Svenson L, Browning E, Lyerly HK, Canton DA, Fisher D, Daud A, Algazi A, Skitzki J, Twitty CG. Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity. Mol Ther Oncolytics 2022;25:174-88. [PMID: 35592387 DOI: 10.1016/j.omto.2022.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liisborg C, Skov V, Kjær L, Hasselbalch HC, Lykke Sørensen T. Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers. PLoS ONE 2022;17:e0269960. [DOI: 10.1371/journal.pone.0269960] [Reference Citation Analysis]
16 Lin C, Chen C, Huang W, Chen Y, Chen S, Chou H, Hung C, Chen W, Lu C, Nian S, Chen S, Chang H, Chang VH, Liu L, Kuo M, Chang S. Restoring Pro-healing/remodeling- associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing. JID Innovations 2022. [DOI: 10.1016/j.xjidi.2022.100138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Martin Calderon L, Pope JE. Precursors to Systemic Sclerosis and Systemic Lupus Erythematosus: From Undifferentiated Connective Tissue Disease to the Development of Identifiable Connective Tissue Diseases. Front Immunol 2022;13:869172. [PMID: 35603174 DOI: 10.3389/fimmu.2022.869172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Kim SK, Cho SW. The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment. Front Pharmacol 2022;13:868695. [DOI: 10.3389/fphar.2022.868695] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
19 Pinjusic K, Dubey OA, Egorova O, Nassiri S, Meylan E, Faget J, Constam DB. Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. J Immunother Cancer 2022;10:e004533. [PMID: 35580932 DOI: 10.1136/jitc-2022-004533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Guerrero D, My Vo HT, Lon C, Bohl JA, Nhik S, Chea S, Man S, Sreng S, Pacheco AR, Ly S, Sath R, Lay S, Missé D, Huy R, Leang R, Kry H, Valenzuela JG, Oliveira F, Cantaert T, Manning JE. First-in-human evaluation of cutaneous innate and adaptive immunomodulation by mosquito bites.. [DOI: 10.1101/2022.04.25.489145] [Reference Citation Analysis]
21 Carbone ML, Madonna G, Capone A, Bove M, Mastroeni S, Levati L, Capone M, Ascierto PA, De Galitiis F, D'Atri S, Fortes C, Volpe E, Failla CM. Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients. Sci Rep 2022;12:5448. [PMID: 35361879 DOI: 10.1038/s41598-022-09373-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Gudowska-sawczuk M, Mroczko B. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? IJMS 2022;23:3673. [DOI: 10.3390/ijms23073673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Zhang J, Wang C, An Q, Quan Q, Li M, Zhao D. Gene Expression Profile Analyses of the Skin Response of Balb/c-Nu Mice Model Injected by Staphylococcus aureus. Clin Cosmet Investig Dermatol 2022;15:217-35. [PMID: 35210800 DOI: 10.2147/CCID.S348961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Bruchard M, Geindreau M, Perrichet A, Truntzer C, Ballot E, Boidot R, Racoeur C, Barsac E, Chalmin F, Hibos C, Baranek T, Paget C, Ryffel B, Rébé C, Paul C, Végran F, Ghiringhelli F. Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses. Nat Immunol. [DOI: 10.1038/s41590-021-01120-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
25 Mura M, Lu P, Atre T, Bolton JS, Duncan EH, Chaudhury S, Bergmann-leitner ES. Immunoprofiling Identifies Functional B and T Cell Subsets Induced by an Attenuated Whole Parasite Malaria Vaccine as Correlates of Sterile Immunity. Vaccines 2022;10:124. [DOI: 10.3390/vaccines10010124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Saluzzo S, Pandey RV, Gail LM, Dingelmaier-Hovorka R, Kleissl L, Shaw L, Reininger B, Atzmüller D, Strobl J, Touzeau-Römer V, Beer A, Staud C, Rieger A, Farlik M, Weninger W, Stingl G, Stary G. Delayed antiretroviral therapy in HIV-infected individuals leads to irreversible depletion of skin- and mucosa-resident memory T cells. Immunity 2021;54:2842-2858.e5. [PMID: 34813775 DOI: 10.1016/j.immuni.2021.10.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
27 Liu Z, Wu X, Hwang ST, Liu J. The Role of Tumor Microenvironment in Mycosis Fungoides and Sézary Syndrome. Ann Dermatol 2021;33:487-96. [PMID: 34858000 DOI: 10.5021/ad.2021.33.6.487] [Reference Citation Analysis]
28 Sorrentino C, Ciummo SL, D'Antonio L, Fieni C, Lanuti P, Turdo A, Todaro M, Di Carlo E. Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. J Immunother Cancer 2021;9:e002966. [PMID: 34663639 DOI: 10.1136/jitc-2021-002966] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zheng X, Higdon L, Gaudet A, Shah M, Balistieri A, Li C, Nadai P, Palaniappan L, Yang X, Santo B, Ginley B, Wang XX, Myakala K, Nallagatla P, Levi M, Sarder P, Rosenberg A, Maltzman JS, de Freitas Caires N, Bhalla V. Endothelial Cell-Specific Molecule-1 Inhibits Albuminuria in Diabetic Mice.. [DOI: 10.1101/2021.10.14.464296] [Reference Citation Analysis]
30 Majumder N, Velayutham M, Bitounis D, Kodali VK, Hasan Mazumder MH, Amedro J, Khramtsov VV, Erdely A, Nurkiewicz T, Demokritou P, Kelley EE, Hussain S. Oxidized carbon black nanoparticles induce endothelial damage through C-X-C chemokine receptor 3-mediated pathway. Redox Biol 2021;47:102161. [PMID: 34624601 DOI: 10.1016/j.redox.2021.102161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Li M, Chen Y, Li H, Yang D, Zhou Y, Chen Z, Zhang Y. Serum CXCL10/IP-10 may be a potential biomarker for severe Mycoplasma pneumoniae pneumonia in children. BMC Infect Dis 2021;21:909. [PMID: 34481469 DOI: 10.1186/s12879-021-06632-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
32 Lindhout IA, Murray TE, Richards CM, Klegeris A. Potential neurotoxic activity of diverse molecules released by microglia. Neurochem Int 2021;148:105117. [PMID: 34186114 DOI: 10.1016/j.neuint.2021.105117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
33 Groß M, Speckmann C, May A, Gajardo-Carrasco T, Wustrau K, Maier SL, Panning M, Huzly D, Agaimy A, Bryceson YT, Choo S, Chow CW, Dückers G, Fasth A, Fraitag S, Gräwe K, Haxelmans S, Holzinger D, Hudowenz O, Hübschen JM, Khurana C, Kienle K, Klifa R, Korn K, Kutzner H, Lämmermann T, Ledig S, Lipsker D, Meeths M, Naumann-Bartsch N, Rascon J, Schänzer A, Seidl M, Tesi B, Vauloup-Fellous C, Vollmer-Kary B, Warnatz K, Wehr C, Neven B, Vargas P, Sepulveda FE, Lehmberg K, Schmitt-Graeff A, Ehl S. Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity. J Allergy Clin Immunol 2021:S0091-6749(21)00809-5. [PMID: 34033843 DOI: 10.1016/j.jaci.2021.05.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
34 Brun P, Conti J, Zatta V, Russo V, Scarpa M, Kotsafti A, Porzionato A, De Caro R, Scarpa M, Fassan M, Calistri A, Castagliuolo I. Persistent Herpes Simplex Virus Type 1 Infection of Enteric Neurons Triggers CD8+ T Cell Response and Gastrointestinal Neuromuscular Dysfunction. Front Cell Infect Microbiol 2021;11:615350. [PMID: 34094993 DOI: 10.3389/fcimb.2021.615350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhao Y, Cai C, Samir J, Palgen JL, Keoshkerian E, Li H, Bull RA, Luciani F, An H, Lloyd AR. Human CD8 T-stem cell memory subsets phenotypic and functional characterization are defined by expression of CD122 or CXCR3. Eur J Immunol 2021;51:1732-47. [PMID: 33844287 DOI: 10.1002/eji.202049057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Cao Y, Hong F, Conlon DM, Sidur L, Smith KM, Fang Y, Cuff CA, Kaymakcalan Z, Ruzek MC. Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa. Br J Dermatol 2021. [PMID: 33811319 DOI: 10.1111/bjd.20097] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
37 Zeng Z, Chew HY, Cruz JG, Leggatt GR, Wells JW. Investigating T Cell Immunity in Cancer: Achievements and Prospects. Int J Mol Sci 2021;22:2907. [PMID: 33809369 DOI: 10.3390/ijms22062907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Marcovecchio PM, Thomas G, Salek-Ardakani S. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer. J Immunother Cancer 2021;9:e002045. [PMID: 33637602 DOI: 10.1136/jitc-2020-002045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
39 Fabian KP, Padget MR, Fujii R, Schlom J, Hodge JW. Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve. J Immunother Cancer 2021;9:e001691. [PMID: 33602696 DOI: 10.1136/jitc-2020-001691] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
40 AbuSamra DB, Panjwani N, Argüeso P. Induction of CXCL10-Mediated Cell Migration by Different Types of Galectins. Cells 2021;10:274. [PMID: 33573183 DOI: 10.3390/cells10020274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sun Y, Chen LH, Lu YS, Chu HT, Wu Y, Gao XH, Chen HD. Identification of novel candidate genes in rosacea by bioinformatic methods. Cytokine 2021;141:155444. [PMID: 33529888 DOI: 10.1016/j.cyto.2021.155444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zhang JA, Zhou XY, Huang D, Luan C, Gu H, Ju M, Chen K. Development of an Immune-Related Gene Signature for Prognosis in Melanoma. Front Oncol 2020;10:602555. [PMID: 33585219 DOI: 10.3389/fonc.2020.602555] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
43 Mommert S, Doenni L, Szudybill P, Zoeller C, Beyer FH, Werfel T. C3a and Its Receptor C3aR Are Detectable in Normal Human Epidermal Keratinocytes and Are Differentially Regulated via TLR3 and LL37. J Innate Immun 2021;13:164-78. [PMID: 33445177 DOI: 10.1159/000512547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Dadey RE, Workman CJ, Vignali DAA. Regulatory T Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1273:105-34. [PMID: 33119878 DOI: 10.1007/978-3-030-49270-0_6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
45 Somasundaram R, Connelly T, Choi R, Choi H, Samarkina A, Li L, Gregorio E, Chen Y, Thakur R, Abdel-Mohsen M, Beqiri M, Kiernan M, Perego M, Wang F, Xiao M, Brafford P, Yang X, Xu X, Secreto A, Danet-Desnoyers G, Traum D, Kaestner KH, Huang AC, Hristova D, Wang J, Fukunaga-Kalabis M, Krepler C, Ping-Chen F, Zhou X, Gutierrez A, Rebecca VW, Vonteddu P, Dotiwala F, Bala S, Majumdar S, Dweep H, Wickramasinghe J, Kossenkov AV, Reyes-Arbujas J, Santiago K, Nguyen T, Griss J, Keeney F, Hayden J, Gavin BJ, Weiner D, Montaner LJ, Liu Q, Peiffer L, Becker J, Burton EM, Davies MA, Tetzlaff MT, Muthumani K, Wargo JA, Gabrilovich D, Herlyn M. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nat Commun 2021;12:346. [PMID: 33436641 DOI: 10.1038/s41467-020-20600-7] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 39.0] [Reference Citation Analysis]
46 Hill LJ, Botfield HF, Begum G, Qureshi O, Vigneswara V, Masood I, Barnes NM, Bruce L, Logan A. ILB® resolves inflammatory scarring and promotes functional tissue repair. NPJ Regen Med 2021;6:3. [PMID: 33414477 DOI: 10.1038/s41536-020-00110-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Lu C, Zhu J, Chen X, Hu Y, Xie W, Yao J, Huang S. Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis. Front Oncol 2020;10:584766. [PMID: 33381455 DOI: 10.3389/fonc.2020.584766] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
48 Kanapeckaitė A, Burokienė N. Novel insights into potential therapeutic targets and biomarkers using integrated multi-omics approaches for dilated and ischemic cardiomyopathies.. [DOI: 10.1101/2020.12.15.422946] [Reference Citation Analysis]
49 Russo E, Santoni A, Bernardini G. Tumor inhibition or tumor promotion? The duplicity of CXCR3 in cancer. J Leukoc Biol 2020;108:673-85. [PMID: 32745326 DOI: 10.1002/JLB.5MR0320-205R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
50 Eiger DS, Boldizsar N, Honeycutt CC, Gardner J, Rajagopal S. Biased agonism at chemokine receptors. Cell Signal 2021;78:109862. [PMID: 33249087 DOI: 10.1016/j.cellsig.2020.109862] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
51 García-Serna AM, Hernández-Caselles T, Jiménez-Guerrero P, Martín-Orozco E, Pérez-Fernández V, Cantero-Cano E, Muñoz-García M, Ballesteros-Meseguer C, Pérez de Los Cobos I, García-Marcos L, Morales E; NELA Study group. Air pollution from traffic during pregnancy impairs newborn's cord blood immune cells: The NELA cohort. Environ Res 2021;198:110468. [PMID: 33217431 DOI: 10.1016/j.envres.2020.110468] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
52 Wang X, Zhang J, Zhou G. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma. J Oral Pathol Med 2021;50:362-70. [PMID: 33187013 DOI: 10.1111/jop.13130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
53 Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA. Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. J Inflamm Res 2020;13:619-33. [PMID: 33061527 DOI: 10.2147/JIR.S270872] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
54 Tang Y, Gu Z, Fu Y, Wang J. CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma. Biosci Rep 2019;39:BSR20192134. [PMID: 31696204 DOI: 10.1042/BSR20192134] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
55 Kurmyshkina O, Kovchur P, Schegoleva L, Volkova T. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion. Int J Mol Sci 2020;21:E6515. [PMID: 32899940 DOI: 10.3390/ijms21186515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Papinska J, Bagavant H, Gmyrek GB, Deshmukh US. Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation. Int J Mol Sci 2020;21:E4512. [PMID: 32630417 DOI: 10.3390/ijms21124512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
57 Scagnolari C, Cannella F, Pierangeli A, Mellinger Pilgrim R, Antonelli G, Rowley D, Wong M, Best S, Xing D, Roden RBS, Viscidi R. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice. J Virol 2020;94:e00087-20. [PMID: 32295905 DOI: 10.1128/JVI.00087-20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
58 Karin N. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Front Immunol 2020;11:976. [PMID: 32547545 DOI: 10.3389/fimmu.2020.00976] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 27.0] [Reference Citation Analysis]
59 Wu X, Sun A, Yu W, Hong C, Liu Z. CXCL10 mediates breast cancer tamoxifen resistance and promotes estrogen-dependent and independent proliferation. Mol Cell Endocrinol 2020;512:110866. [PMID: 32417506 DOI: 10.1016/j.mce.2020.110866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
60 Duval KEA, Vernice NA, Wagner RJ, Fiering SN, Petryk JD, Lowry GJ, Tau SS, Yin J, Houde GR, Chaudhry AS, Hoopes PJ. Immunogenetic effects of low dose (CEM43 30) magnetic nanoparticle hyperthermia and radiation in melanoma cells. Int J Hyperthermia 2019;36:37-46. [PMID: 31795829 DOI: 10.1080/02656736.2019.1627433] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
61 Mehta M, Dhanjal DS, Paudel KR, Singh B, Gupta G, Rajeshkumar S, Thangavelu L, Tambuwala MM, Bakshi HA, Chellappan DK, Pandey P, Dureja H, Charbe NB, Singh SK, Shukla SD, Nammi S, Aljabali AA, Wich PR, Hansbro PM, Satija S, Dua K. Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacol 2020;28:795-817. [DOI: 10.1007/s10787-020-00698-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 19.5] [Reference Citation Analysis]
62 Kremenovic M, Schenk M, Lee DJ. Clinical and molecular insights into BCG immunotherapy for melanoma. J Intern Med 2020;288:625-40. [PMID: 32128919 DOI: 10.1111/joim.13037] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
63 Flores-Guzmán F, Utikal J, Umansky V. Dormant tumor cells interact with memory CD8+ T cells in RET transgenic mouse melanoma model. Cancer Lett 2020;474:74-81. [PMID: 31962142 DOI: 10.1016/j.canlet.2020.01.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
64 Ma B, Khazali A, Shao H, Jiang Y, Wells A. Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer. Cell Commun Signal 2019;17:164. [PMID: 31831069 DOI: 10.1186/s12964-019-0489-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Tuong ZK, Lewandowski A, Bridge JA, Cruz JLG, Yamada M, Lambie D, Lewandowski R, Steptoe RJ, Leggatt GR, Simpson F, Frazer IH, Soyer HP, Wells JW. Cytokine/chemokine profiles in squamous cell carcinoma correlate with precancerous and cancerous disease stage. Sci Rep 2019;9:17754. [PMID: 31780824 DOI: 10.1038/s41598-019-54435-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Rahman MM, Lai YC, Husna AA, Chen HW, Tanaka Y, Kawaguchi H, Hatai H, Miyoshi N, Nakagawa T, Fukushima R, Miura N. Transcriptome analysis of dog oral melanoma and its oncogenic analogy with human melanoma. Oncol Rep 2020;43:16-30. [PMID: 31661138 DOI: 10.3892/or.2019.7391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
67 Howell MD, Kuo FI, Smith PA. Targeting the Janus Kinase Family in Autoimmune Skin Diseases. Front Immunol 2019;10:2342. [PMID: 31649667 DOI: 10.3389/fimmu.2019.02342] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 22.7] [Reference Citation Analysis]
68 Rauschenberger T, Schmitt V, Azeem M, Klein-Hessling S, Murti K, Grän F, Goebeler M, Kerstan A, Klein M, Bopp T, Serfling E, Muhammad K. T Cells Control Chemokine Secretion by Keratinocytes. Front Immunol 2019;10:1917. [PMID: 31447864 DOI: 10.3389/fimmu.2019.01917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
69 Sun Y, Xie M, Wu S, Zhang J, Huang C. Identification and Interaction Analysis of Key Genes and MicroRNAs in Systemic Sclerosis by Bioinformatics Approaches. CURR MED SCI 2019;39:645-52. [DOI: 10.1007/s11596-019-2086-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
70 Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, Regazzetti C, Beranger GE, Lereverend C, Pons C, Khemis A, Ballotti R, Bertolotto C, Rocchi S, Passeron T. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat Commun 2019;10:2178. [PMID: 31097717 DOI: 10.1038/s41467-019-09963-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 17.3] [Reference Citation Analysis]
71 Xiong Y, Mi BB, Liu MF, Xue H, Wu QP, Liu GH. Bioinformatics Analysis and Identification of Genes and Molecular Pathways Involved in Synovial Inflammation in Rheumatoid Arthritis. Med Sci Monit 2019;25:2246-56. [PMID: 30916045 DOI: 10.12659/MSM.915451] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]